BOPA member published in the Journal of Oncology Pharmacy Practice

International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions

Immunotherapy is an evolving therapeutic modality which confers a range of clinical advantages in the treatment of malignant disease. Oncology pharmacists, pharmacy technicians and assistants are key members of the multidisciplinary health care team caring for patients receiving immunotherapy. The International Society of Oncology Pharmacy Practitioners (ISOPP) has developed a position statement to provide guidance to pharmacy professionals working in this field and to promote the role that pharmacy staff have to offer in providing safe and effective treatment with immunotherapy.

Four key recommendations were identified:

1) participation as an integrated, collaborative member of the MHT

1) provision of education and training for patients, students, residents, fellows and other members of the MHT

3) involvement in clinical governance to optimise the use of immune checkpoint inhibitors

4) involvement in research and development in the field of immunotherapy.

 

Read the full article here: https://journals.sagepub.com/doi/10.1177/10781552221090199 

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article